Copyright © 2025 KAP
Central Securities Depository & Trade Repository of Türkiye
| ||||||||||||||||||||||
General Assembly Invitation | ||||||||||||||||||||||
| ||||||||||||||||||||||
Agenda Items | ||||||||||||||||||||||
1 - Openingand election of Chairing Committee and authorization of Chairing Committee for signing the Minutes of the General Assembly Meeting, | ||||||||||||||||||||||
2 - Readingand discussion of the AnnualReport of the Board of Directors for the fiscal year 2024, | ||||||||||||||||||||||
3 - Readingthe independent auditreport prepared by the Independent Auditor, DRT Bağımsız Denetim ve Serbest Muhasebeci Mali Müşavirlik Anonim Şirketi, | ||||||||||||||||||||||
4 - Reading,discussion and approval of the financial statements of thefiscal year 2024, | ||||||||||||||||||||||
5 - Discussion and resolution of the matter concerning the release of the members of the Board of Directors individually, who have performed in the fiscal year 2024, from their liabilities for the operations, proceedings and accounts, | ||||||||||||||||||||||
6 - Reading, discussion and approval of the Board of Directors' proposal for dividend distribution for the fiscal year 2024, | ||||||||||||||||||||||
7 - Determination of remuneration of the members of the Board of Directors for the following fiscal year, | ||||||||||||||||||||||
8 - Determination of the number and terms of office of the new members of the Board of Directors, as well as the election of members of the Board of Directors and Independent Board Members to serve for the period to be determined, | ||||||||||||||||||||||
9 - Approval of the appointment of the Independent Auditor for the fiscal year 2025, as proposed by the Board of Directors to complete the term of office of the previous member, in accordance with the Capital Markets Board regulations and related legislation, | ||||||||||||||||||||||
10 - Informing the Shareholders about the "Remuneration Policy" with respect to the members of the Board of Directors and the Senior Executives, in accordance with the Communiqué on Corporate Governance No. II-17.1 of the Capital Markets Board, | ||||||||||||||||||||||
11 - Informing the General Assembly about the donations made by the Company within the fiscal year 2024; | ||||||||||||||||||||||
12 - Determination of an upper limit for the grants and donations to be valid for the fiscal year 2025 and discussion on authorization of the Board of Directors to act within the limits determined relating thereto in accordance with the Capital Markets Board regulations and submitting to the approval of the General Assembly; | ||||||||||||||||||||||
13 - Informing the General Assembly about the share buy-back transactions executed during 2024 pursuant to the "Share Buy-Back Program" adopted during the Extraordinary General Assembly Meeting on 18 December 2024, | ||||||||||||||||||||||
14 - Requesting the General Assembly's approval for the acts and transactions to be executed by the members of the Board of Directors pursuant to Articles 395 and 396 of the Turkish Commercial Code; | ||||||||||||||||||||||
15 - Informingthe Shareholders about any material transactions that may create conflict of interest with the Company or its affiliates and/or about a transaction of commercial nature made on personal account or on behalf of any others that is listed in the commercial activities of the company or of its affiliates or participating to another partnership that is engaged with the same commercial activities with the title of a partner with unlimited liability, by any of the shareholders controlling the company, members of the Board of Directors, executives with administrative responsibility and their spouses and relatives related by blood or affinity up to the second degree; | ||||||||||||||||||||||
16 - Informingthe Shareholders thatno liens, pledgesor such assurances have been given, or no benefits have been created on behalf of Company's Shareholders and third parties, in accordance with the Capital Markets Legislation and the Capital Markets Board's Communiqué on Corporate Governance No II-17.1; | ||||||||||||||||||||||
17 - Wishes and closing. | ||||||||||||||||||||||
Corporate Actions Involved In Agenda | ||||||||||||||||||||||
| ||||||||||||||||||||||
General Assembly Results | ||||||||||||||||||||||
| ||||||||||||||||||||||
Decisions Regarding Corporate Actions | ||||||||||||||||||||||
| ||||||||||||||||||||||
General Assembly Registry | ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
Additional Explanations | ||||||||||||||||||||||
Our company's 2024 General Assembly Meeting, held on 14 April 2025, has been registered by Gebze Trade Registry Office on 15 April 2025. |
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.
PDF
WORD
EXCEl